Page last updated: 2024-08-16

resveratrol and Infections, Respiratory

resveratrol has been researched along with Infections, Respiratory in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	3 (50.00)	24.3611
2020's	2 (33.33)	2.80

Authors

Authors	Studies
Antonini, S; Becherucci, P; Biasci, P; Bortone, B; Bottero, S; Caldarelli, V; Cardinale, F; Chiappini, E; Ciarcià, M; Ciofi, D; Cutrera, R; D'Elios, S; de Martino, M; Del Giudice, MM; Di Mauro, G; Doria, M; Galli, L; Gattinara, GC; Indinnimeo, L; Lo Vecchio, A; Macrì, F; Marchisio, P; Marseglia, GL; Mattina, R; Miniello, VL; Morbin, G; Motisi, MA; Novelli, A; Palamara, AT; Panatta, ML; Pasinato, A; Peroni, D; Perruccio, K; Piacentini, G; Pifferi, M; Pignataro, L; Santamaria, F; Sitzia, E; Tersigni, C; Torretta, S; Trambusti, I; Trippella, G; Valentini, D; Valentini, S; Varricchio, A; Verga, MC; Vicini, C; Villani, A; Zecca, M	1
Di Pietro, M; Filardo, S; Mastromarino, P; Sessa, R	1
Barberán, M; Caturla, N; Díez-Martínez, R; Euba, B; Fernández-Calvet, A; Garmendia, J; López-López, N; Martí, S; Rodríguez-Arce, I	1
Campana, G; Capasso, M; Ciprandi, G; Decimo, F; Leonardi, S; Maiello, N; Miraglia Del Giudice, M	1
Capasso, M; Ciprandi, G; Della Volpe, A; Malafronte, L; Mansi, N; Varricchio, A; Varricchio, AM	1
De Vecchi, E; Drago, L; Nicola, L; Ossola, F	1

Reviews

1 review(s) available for resveratrol and Infections, Respiratory

Article	Year
Therapeutic potential of resveratrol against emerging respiratory viral infections. Pharmacology & therapeutics, 2020, Volume: 214 Topics: Antiviral Agents; Betacoronavirus; Communicable Diseases, Emerging; Coronavirus Infections; COVID-19; Humans; Influenza, Human; Pandemics; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Resveratrol; SARS-CoV-2; Virus Diseases	2020

Article

Year

Therapeutic potential of resveratrol against emerging respiratory viral infections.

Pharmacology & therapeutics, 2020, Volume: 214

Topics: Antiviral Agents; Betacoronavirus; Communicable Diseases, Emerging; Coronavirus Infections; COVID-19; Humans; Influenza, Human; Pandemics; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Resveratrol; SARS-CoV-2; Virus Diseases

2020

Trials

2 trial(s) available for resveratrol and Infections, Respiratory

Article	Year
Resveratrol plus carboxymethyl-β-glucan may affect respiratory infections in children with allergic rhinitis. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2014, Volume: 25, Issue:7 Topics: Adolescent; Child; Child, Preschool; Chitin; Drug Combinations; Fallopia japonica; Female; Glucans; Humans; Male; Nasal Sprays; Recurrence; Respiratory Tract Infections; Resveratrol; Rhinitis, Allergic; Stilbenes; Treatment Outcome	2014
Resveratrol plus carboxymethyl-β-glucan in children with recurrent respiratory infections: a preliminary and real-life experience. Italian journal of pediatrics, 2014, Nov-23, Volume: 40 Topics: Anti-Inflammatory Agents, Non-Steroidal; beta-Glucans; Child; Cytarabine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Life Change Events; Male; Recurrence; Respiratory Tract Infections; Resveratrol; Stilbenes; Treatment Outcome; Vasodilator Agents	2014

Article

Year

Resveratrol plus carboxymethyl-β-glucan may affect respiratory infections in children with allergic rhinitis.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2014, Volume: 25, Issue:7

Topics: Adolescent; Child; Child, Preschool; Chitin; Drug Combinations; Fallopia japonica; Female; Glucans; Humans; Male; Nasal Sprays; Recurrence; Respiratory Tract Infections; Resveratrol; Rhinitis, Allergic; Stilbenes; Treatment Outcome

2014

Resveratrol plus carboxymethyl-β-glucan in children with recurrent respiratory infections: a preliminary and real-life experience.

Italian journal of pediatrics, 2014, Nov-23, Volume: 40

Topics: Anti-Inflammatory Agents, Non-Steroidal; beta-Glucans; Child; Cytarabine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Life Change Events; Male; Recurrence; Respiratory Tract Infections; Resveratrol; Stilbenes; Treatment Outcome; Vasodilator Agents

2014

Other Studies

3 other study(ies) available for resveratrol and Infections, Respiratory

Article	Year
Prevention of recurrent respiratory infections : Inter-society Consensus. Italian journal of pediatrics, 2021, Oct-25, Volume: 47, Issue:1 Topics: Adenoidectomy; Adjuvants, Immunologic; Administration, Intranasal; Algorithms; Antibiotic Prophylaxis; Antioxidants; Child; Complementary Therapies; Humans; Hyaluronic Acid; Influenza Vaccines; Pneumococcal Vaccines; Prebiotics; Probiotics; Pyrrolidonecarboxylic Acid; Recurrence; Respiratory Tract Infections; Resveratrol; Thiazolidines; Tonsillectomy; Vitamins	2021
Resveratrol therapeutics combines both antimicrobial and immunomodulatory properties against respiratory infection by nontypeable Haemophilus influenzae. Scientific reports, 2017, 10-16, Volume: 7, Issue:1 Topics: A549 Cells; Administration, Intranasal; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; beta-Defensins; Cells, Cultured; Drug Resistance, Bacterial; Epithelial Cells; Gene Expression Regulation, Neoplastic; Haemophilus Infections; Haemophilus influenzae; Humans; Immunologic Factors; Interleukin-8; Mice; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Resveratrol; Zebrafish	2017
In vitro antiviral activity of resveratrol against respiratory viruses. Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:3 Topics: Adenoviridae; Antioxidants; Antiviral Agents; Cell Line; Humans; Influenza A virus; Respiratory Syncytial Viruses; Respiratory Tract Infections; Resveratrol; Stilbenes	2008